'

DFNS.net CBRN News Blog

0

US resists extension of Iran nuclear talks

Vienna (AFP) Oct 15, 2014 – Iran and the US still aim to strike a mammoth nuclear deal by a November 24 deadline, a US official said Wednesday after talks involving US Secretary of...

0

Pandora Report 10.26.14

This late weekend Pandora Report covers antibiotics in fish, ISIS and chemical weapons, the UN and Cholera, and, of course, an Ebola update. Don’t forget to get your flu shot, and remember to protect...

0

Biodefense News Headlines of the Week – October 26, 2014

Leaked documents reveal behind-the-scenes Ebola vaccine issues | Iraqi officials say IS militants used chlorine gas | Tested negative for Ebola, nurse criticizes her quarantine | BioFire expands in Utah, readies for release of...

0

Rules of the Road for Ebola Crisis Volunteers

A recent article published by the Disaster Medicine and Public Health Preparedness Journal (DMPHP) outlines considerations for humanitarian volunteers thinking about deploying to Ebola-stricken areas. Written by a consortium of Boston-based hospitals, the article...

0

Winning the War Against Human Parainfluenza Virus

Researchers at Griffith University’s Institute for Glycomics have moved a step closer to identifying a treatment for the Human parainfluenza virus (hPIV). These highly-infectious viruses are the leading cause of upper and lower respiratory...

0

New Bat Flu Found

By Jonathon Marionaux Halloween is right around the corner, so we continue our coverage of one of the most notable creatures of the season: bats. Previously we covered vampire bats and their role in...

0

ISIS and Chemical Weapons

The Washington Post has reported that ISIS used an improvised chemical weapon containing chlorine to attack an Iraqi police patrol in Balad, north of Baghdad, in September, injuring 11 officers. Chlorine is readily available...

0

Mali becomes sixth West African nation hit by Ebola

REUTERS – Mali confirmed its first case of Ebola on Thursday, becoming the sixth West African country to be touched by the worst outbreak on record of the hemorrhagic fever, which has killed nearly...

0

MILAN ER cleared for production

On October 15, MBDA completed a firing campaign intended to validate the series production of the MILAN Extended Response (ER) anti-tank missile. This followed qualification of the MILAN ER weapon system during the first...

0

PAC-3 MSE readied for production

Work on long-lead-time components for the Lockheed Martin Patriot Advanced Capability-3 (PAC-3) Missile Segment Enhancement (MSE) missiles is now under way. Production of the PAC-3 MSE, which has been under development since June 2003,...

0

Improved data reveals higher global burden of tuberculosis

WorldHealthOrganization: Recent intensive efforts to improve collection and reporting of data on tuberculosis (TB) are shedding new light on the epidemic, revealing that there are almost half a million more cases of the disease...

0

WHO declares end of Ebola outbreak in Nigeria

WorldHealthOrganization: On October 20, Nigeria reached the 42-day mark of having no new cases of Ebola detected and has thus been declared free of Ebola transmission. …read more From:: Virtual Biosecurity Center

0

Image of the Day: Ebola Infographic!

If you love infographics as much as I do (and I’m sure you do) you’ll appreciate this one created by Waka Waka. Forward and share with friends and colleagues, because remember, sharing is caring...

0

Tekmira Starts Limited Manufacturing of Ebola Therapeutic

Tekmira Pharmaceuticals yesterday announced it has commenced limited GMP manufacture of TKM-Ebola, an RNAi therapeutic specifically targeting the Ebola – Guinea virus variant. Tekmira has completed the design of a modified RNAi therapeutic specifically...

0

Why Some Adults Were More Susceptible To Last Year’s Flu

A team of scientists has identified a possible explanation for why middle-aged adults were hit especially hard by the H1N1 influenza virus during the 2013-2014 influenza season. The findings offer evidence that a new...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close